[2] GONCALVES I L, DAS NEVES G M, KAGAMI L P, et al. Discovery, development, chemical diversity and design of isoxazoline-based insecticides[J]. Bioorganic & Medicinal Chemistry, 2021,30: 115934.
[3] SHENG C W, JIA Z Q, LIU D, et al. Insecticidal spectrum of fluralaner to agricultural and sanitary pests[J]. Journal of Asia-Pacific Entomology, 2017, 20(4): 1213-1218.
[4] GAECIA-REYNAGA P, ZHAO C, SARPONG R,et al. New GABA/glutamate receptor target for [3H] isoxazoline insecticide[J]. Chemical Research in Toxicology, 2013, 26(4): 514-516.
[5] GASSEL M, WOLF C, NOACK S, et al. The novel isoxazoline ectoparasiticide fluralaner: selective inhibition of arthropod γ-aminobutyric acid-and L-glutamate-gated chloride channels and insecticidal/acaricidal activity[J]. Insect Biochemistry and Molecular Biology, 2014, 45: 111-124.
[6] CASIDA J E, DURKIN K A. Novel GABA receptor pesticide targets[J]. Pesticide Biochemistry and Physiology, 2015, 121: 22-30.
[7] WEBER T, SELZER P M. Isoxazolines: a novel chemotype highly effective on ectoparasites[M]. Ectoparasites: Drug Discovery Against Moving Targets, 2018: 243-258.
[8] CASIDA J E. Golden age of RyR and GABA-R diamide and isoxazoline insecticides: common genesis, serendipity, surprises, selectivity, and safety[J]. Chemical Research in Toxicology, 2015, 28(4): 560-566.
[9] 巨修练. GABAA 受体及其非竞争性拮抗剂的研究进展[J]. 世界农药, 2007, 29(1): 28-33.
[10] BLYTHE J, EARLEY F G P, PIEKARSKA-HACK K, et al. The mode of action of isocycloseram: a novel isoxazoline insecticide[J]. Pesticide Biochemistry and Physiology,2022,187:105217:1-11.
[11] 陈佳丽, 翟纳, 陈达, 等. 亚氨基哒嗪类衍生物对人与昆虫 GABA 受体的选择性研究[J]. 武汉工程大学学报, 2019, 41(1):12-18.
[12] ROHDICH N, ROEPKE R K A, ZSCHIESCHE E. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto?(fluralaner) against Frontline?(fipronil) in flea-and tick-infested dogs[J]. Parasites & Vectors, 2014, 7(1): 1-5.
[13] FISARA P, WEBSTER M. A randomized controlled trial of the efficacy of orally administered fluralaner (BravectoTM) against induced Ixodes holocyclus (Australian paralysis tick) infestations on dogs[J]. Parasites & Vectors, 2015, 8(1): 1-6.
[14] SHOOP W L, HARTLINE E J, GOULD B R, et al. Discovery and mode of action of afoxolaner, a new isoxazoline parasiticide for dogs[J]. Veterinary Parasitology, 2014, 201(3/4): 179-189.
[15] HAMPEL V, KNAUS M, SCHAFER J, et al. TreaGent of canine sarcoptic mange with afoxolaner (NexGard?) and afoxolaner plus milbemycin oxime (NexGard Spectra?) chewable tablets: efficacy under field conditions in Portugal and Germany[J]. Parasite, 2018, 25: 63-71.
[16] CURTIS M P, VAILLANCOURT V, GOODWIN R M, et al. Design and synthesis of sarolaner, a novel, once-a-month, oral isoxazoline for the control of fleas and ticks on dogs[J]. Bioorganic & Medicinal Chemistry Letters, 2016, 26(7): 1831-1835.
[17] SIX R H, BECSKEI C, MAZALESKI M M, et al. Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis[J]. Veterinary Parasitology, 2016, 222: 62-66.
[18] RUFENER L, DANELLI V, BERTRAND D, et al. The novel isoxazoline ectoparasiticide lotilaner (Credelio?): a non-competitive antagonist specific to invertebrates γ-aminobutyric acid-gated chloride channels (GABACls)[J]. Parasites & Vectors, 2017, 10(1): 1-15.
[19] LITTLE S E. Lotilaner-a novel systemic tick and flea control product for dogs[J]. Parasites & Vectors, 2017, 10(1): 1-3.
[20] ASAHI M, KOBAYASHI M, KAGAMI T, et al. Fluxametamide: a novel isoxazoline insecticide that acts via distinctive antagonism of insect ligand-gated chloride channels[J]. Pesticide Biochemistry and Physiology, 2018, 151: 67-72.
[21] LI Y, WANG Y N ,QIAN C L , et al. Lethal and sublethal effects of fluxametamide on rice-boring pest, rice stem borer Chilo suppressalis[J]. Agronomy, 2022, 12: 2429:1-11.